跳至主要内容
临床试验/NL-OMON38604
NL-OMON38604已完成4 期

QTc-prolongation in the use of antidepressants for anxiety-disorders - QT-prolongation in AD use in Anxietydisorders (QADA)

Parnassia (Den Haag)0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age between 18 and 55 years.
  • - Under treatment of the department of Anxiety Disorders, PsyQ, The Hague.
  • - Indication to start with antidepressant medication and not known to have a contra-indication to start with this kind of medication, e.g. severe liver dysfunction, long QT-syndrome, recent myocardial infarct.
  • - Able and willing to give informed consent.

排除标准

  • - Patients who had used already antidepressant medication in the 6 weeks prior to the inclusion.
  • - Patients who already use QT-prolonging anti-arrhythmic medication (e.g. sotalol, amiodarone).
  • - Patients who do not meet inclusion-criteria.

研究者

发起方
Parnassia (Den Haag)

相似试验